Nilotinib (Tasigna®) for the newly diagnosed Chronic Phase Philadelpha Chromosone positive CML.
Rapid Review
| Commenced | Completed | Outcome |
| 06/10/2010 | 22/10/2010 | Full Pharmacoeconomic Evaluation Recommended. |
Nilotinib (Tasigna®) for the newly diagnosed Chronic Phase Philadelpha Chromosone positive CML.
Rapid Review
| Commenced | Completed | Outcome |
| 06/10/2010 | 22/10/2010 | Full Pharmacoeconomic Evaluation Recommended. |